Related references
Note: Only part of the references are listed.Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
Parvathi Sudha et al.
CLINICAL CANCER RESEARCH (2022)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity
Antonio Sacco et al.
BLOOD (2021)
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Ana Jimenez-Ubieto et al.
BLOOD (2021)
Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing
Miyoung Kim et al.
PLOS ONE (2021)
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Alejandro Medina et al.
BLOOD CANCER JOURNAL (2020)
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma
Irena Misiewicz-Krzeminska et al.
BLOOD ADVANCES (2020)
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker et al.
LEUKEMIA (2019)
High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma
Anjan Thakurta et al.
BLOOD (2019)
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
Laura Rosinol et al.
BLOOD (2019)
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Venkata Yellapantula et al.
BLOOD CANCER JOURNAL (2019)
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A. Walker et al.
BLOOD (2018)
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Yanira Ruiz-Heredia et al.
HAEMATOLOGICA (2018)
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Yanira Ruiz-Heredia et al.
HAEMATOLOGICA (2018)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma
Cristina Jimenez et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
J. Martinez-Lopez et al.
LEUKEMIA (2017)
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group
Pieter Sonneveld et al.
BLOOD (2016)
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
Merav Leiba et al.
GENES CHROMOSOMES & CANCER (2016)
Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients
K. M. Kortuem et al.
BLOOD CANCER JOURNAL (2016)
Vidjil: A Web Platform for Analysis of High-Throughput Repertoire Sequencing
Marc Duez et al.
PLOS ONE (2016)
Sambamba: fast processing of NGS alignment formats
Artem Tarasov et al.
BIOINFORMATICS (2015)
Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience
Benjamin Hebraud et al.
BLOOD (2015)
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
LUMPY: a probabilistic framework for structural variant discovery
Ryan M. Layer et al.
GENOME BIOLOGY (2014)
Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myelome Experience
Herve Avet-Loiseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CONTRA: copy number analysis for targeted resequencing
Jason Li et al.
BIOINFORMATICS (2012)
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Tobias Rausch et al.
BIOINFORMATICS (2012)
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Bruno Paiva et al.
BLOOD (2012)
Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
Shaji Kumar et al.
BLOOD (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes
Simone Ferrero et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Can we change the disease biology of multiple myeloma?
Ivan Borrello
LEUKEMIA RESEARCH (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
Share Paper
